Global Animal Model Market to Reach US$ 3,066.0 Million by 2032, Propelled by Rising Demand for Effective Therapies

May 25, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Animal Model Market Report by Animal Type (Rat, Mice, Guinea Pigs, Rabbits, and Others), Technology (CRISPR, Embryonic Stem Cell Injection, Nuclear Transfer, and Others), Application (Drug Discovery and Development, Basic Research, and Others), End User (Pharma and Biotech Companies, Academic Research Institutes, and Others), and Region 2024-2032," the global animal model market size reached US$ 1,810.1 Million in 2023. Animal models refer to the non-human species used in biomedical research to mimic the aspects of biological processes and diseases found in humans. They include rats, mice, zebrafish, rabbits, monkeys, dogs, hamsters, and pigs. They are widely used for studying disease mechanisms, drug discovery and development, preclinical testing, drug screening, target validation, pharmacokinetics studies, biomarker identification, and genetic studies. Animal models aid in evaluating the safety and efficacy of vaccines, identifying factors that influence drug metabolism, and assessing potential side effects of the drug delivery systems. They also assist researchers in optimizing clinical trials, gaining deeper insights into disease progression, refining treatment regimes, and assessing the optimal dosage quantity.

Global Animal Model Market Trends:

The rising demand for effective therapies across the globe is one of the primary factors propelling the market growth. Animal models are widely used to assess the safety, efficacy, and toxicity of drug candidates, determine safe dosage ranges, optimize formulations, identify best administration routes, and minimize the risk of adverse side effects in human subjects. Furthermore, the growing prevalence of chronic conditions, such as cancer, neurological disorders, acute infections, and cardiovascular diseases (CVDs), is facilitating the demand for animal models to understand disease mechanisms, identify drug targets, and assess the efficacy of potential treatment options. Additionally, the utilization of advanced gene editing tools, such as clustered regularly interspaced short palindromic repeats (CRISPR-Cas9), to create animal models with precise genetic modifications to study human genetic diseases and identify the underlying mechanism is positively influencing the market growth. Besides this, the recent development of humanized animal models by introducing human genes, tissues, and immune cells into animals to study human-specific diseases and test the efficacies of various therapeutics is contributing to the market growth. Moreover, the implementation of strict government regulations to mandate preclinical testing using animal models to ensure drug safety and efficacy is supporting the market growth. Other factors, including growing demand for personalized medicines, extensive research and development (R&D) activities, and significant growth in the pharmaceutical industry, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 3,066.0 Million by 2032, exhibiting a CAGR of 5.8% during 2024-2032.

Market Summary:

  • On the basis of the animal type, the market has been divided into rat, mice, guinea pig, rabbits, and others.
  • Based on the technology, the market has been classified into CRISPR, embryonic stem cell injection, nuclear transfer, and others.
  • On the basis of the application, the market has been divided into drug discovery and development, basic research, and others.
  • Based on the end user, the market has been classified into pharma and biotech companies, academic research institutes, and others.
  • On a regional basis, the market has been categorized into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
  • The competitive landscape of the industry has also been examined, with some of the key players being Biocytogen, Charles River Laboratories International Inc, Envigo, Eurofins Scientific SE, GenOway S.A., Hera BioLabs, JSR Corporation, Ozgene Pty Ltd., PerkinElmer Inc., Taconic Biosciences Inc., The Jackson Laboratory and Trans Genic Inc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Segment Coverage Animal Type, Technology, Application, End User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Biocytogen, Charles River Laboratories International Inc, Envigo, Eurofins Scientific SE, GenOway S.A., Hera BioLabs, JSR Corporation, Ozgene Pty Ltd., PerkinElmer Inc., Taconic Biosciences Inc., The Jackson Laboratory and Trans Genic Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Animal Model Market to Reach US$ 3,066.0 Million by 2032, Propelled by Rising Demand for Effective Therapies
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More